Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS)
Clinical trial NCT01199861 · COMPLETED
Trial details
- NCT number
- NCT01199861
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2011-05-01
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.